1958, from "phthalimidoglutarimide," based on abbreviated form of naphthalene; a morning-sickness drug responsible for severe birth defects in Europe from 1956 to 1961, when it was withdrawn. It never was approved for use in America thanks to the efforts of Dr. Helen Brooke Taussig (1898-1986). Thalidomide baby is attested from 1962.